Livros
Cadernos de Formação
Artigos Publicados pelo GEDII
Prospective study of blood viral load of Epstein-Barr virus, herpes virus type 6 and human parvovirus B19 in Crohn's disease: Does therapy matter?
J Clin Virol. 2020
Methylation patterns in dysplasia in inflammatory bowel disease patients.
Scand J Gastroenterol. 2020
Transmural Histological Scoring Systems in Crohn's Disease: A Systematic Review With Assessment of Methodological Quality and Operating Properties.
J Crohns Colitis. 2020
Comparison of the Nancy index with continuous Geboes score: histological remission and response in ulcerative colitis.
J Crohns Colitis. 2020
Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020
Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review.
Clin Gastroenterol Hepatol. 2020
Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study.
Inflamm Bowel Dis. 2020
Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels.
J Crohns Colitis. 2020
Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab.
Therap Adv Gastroenterol. 2019
Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Surgical Intervention versus Immunomodulatory Therapy.
Digestion. 2019
What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale.
Therap Adv Gastroenterol. 2019
Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study.
J Crohns Colitis. 2019
Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years.
Dig Liver Dis. 2019
Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis.
J Crohns Colitis. 2019
Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis.
J Crohns Colitis. 2018
The timing of early therapeutic strategies has a significant impact on Crohn's disease prognosis.
Dig Liver Dis. 2018
Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels.
Gut. 2019
Disagreement Among Gastroenterologists Using the Mayo and Rutgeerts Endoscopic Scores.
Fernandes SR, Pinto JSLD, Marques da Costa P, Correia L; GEDII.
Inflamm Bowel Dis. 2018
A Systematic Review and Meta-Analysis of 6-Thioguanine Nucleotide Levels and Clinical Remission in Inflammatory Bowel Disease.
J Crohns Colitis. 2017
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation.
EBioMedicine. 2017
Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.
J Crohns Colitis. 2017
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays.
Therap Adv Gastroenterol. 2016
Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.
J Crohns Colitis. 2017
Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.
J Crohns Colitis. 2017
Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays.
Aliment Pharmacol Ther. 2016
[Portuguese Consensus on the Diagnosis, Prevention and Treatment of Anaemia in Inflammatory Bowel Disease].
Acta Med Port. 2016
Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab.
J Crohns Colitis. 2016
Anaemia in Patients with Inflammatory Bowel Disease - A Nationwide Cross-Sectional Study.
Digestion. 2016
In vitro evaluation of traditionally used Surinamese medicinal plants for their potential anti-leishmanial efficacy.
J Ethnopharmacol. 2016
Assessing overall patient satisfaction in inflammatory bowel disease using structural equation modeling.
Eur J Gastroenterol Hepatol. 2015
Clinical practice in Crohn's disease in bordering regions of two countries: different medical options, distinct surgical events.
J Crohns Colitis. 2010
Ulcerative colitis in northern Portugal and Galicia in Spain.
Inflamm Bowel Dis. 2010
Ulcerative colitis in a Southern European country: a national perspective.
Inflamm Bowel Dis. 2010
Crohn's disease in a southern European country: Montreal classification and clinical activity.
Inflamm Bowel Dis. 2009
Inflammatory bowel disease: a patient's and caregiver's perspective.
Dig Dis Sci. 2009
Abstracts GEDII
2008
Journal of Crohn and Colitis Suplements - Abstracts of the 3rd ECCO Congress
Jornal Português de Gastrenterologia - Vilamoura 4 a 7 de Junho de 2008
2007
Jornal Português de Gastrenterologia - XXVII Congresso Nacional de Gastrenterologia e Endoscopia Digestiva
- Doença Inflamatória intestinal Tópicos de relevância clínica
- Inflammatory Bowel Disease a Clinicopathological Approach
- Terapêutica Farmacológica na Doença Inflamatória Intestinal
Cadernos de Formação
- Cadernos de Formação em Gastrenterologia: Doença de Crohn
Artigos Publicados pelo GEDII
Prospective study of blood viral load of Epstein-Barr virus, herpes virus type 6 and human parvovirus B19 in Crohn's disease: Does therapy matter?
J Clin Virol. 2020
Methylation patterns in dysplasia in inflammatory bowel disease patients.
Scand J Gastroenterol. 2020
Transmural Histological Scoring Systems in Crohn's Disease: A Systematic Review With Assessment of Methodological Quality and Operating Properties.
J Crohns Colitis. 2020
Comparison of the Nancy index with continuous Geboes score: histological remission and response in ulcerative colitis.
J Crohns Colitis. 2020
Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2020
Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review.
Clin Gastroenterol Hepatol. 2020
Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study.
Inflamm Bowel Dis. 2020
Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels.
J Crohns Colitis. 2020
Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab.
Therap Adv Gastroenterol. 2019
Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Surgical Intervention versus Immunomodulatory Therapy.
Digestion. 2019
What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale.
Therap Adv Gastroenterol. 2019
Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study.
J Crohns Colitis. 2019
Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years.
Dig Liver Dis. 2019
Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis.
J Crohns Colitis. 2019
Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis.
J Crohns Colitis. 2018
The timing of early therapeutic strategies has a significant impact on Crohn's disease prognosis.
Dig Liver Dis. 2018
Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels.
Gut. 2019
Disagreement Among Gastroenterologists Using the Mayo and Rutgeerts Endoscopic Scores.
Fernandes SR, Pinto JSLD, Marques da Costa P, Correia L; GEDII.
Inflamm Bowel Dis. 2018
A Systematic Review and Meta-Analysis of 6-Thioguanine Nucleotide Levels and Clinical Remission in Inflammatory Bowel Disease.
J Crohns Colitis. 2017
Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation.
EBioMedicine. 2017
Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.
J Crohns Colitis. 2017
Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays.
Therap Adv Gastroenterol. 2016
Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions.
J Crohns Colitis. 2017
Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.
J Crohns Colitis. 2017
Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays.
Aliment Pharmacol Ther. 2016
[Portuguese Consensus on the Diagnosis, Prevention and Treatment of Anaemia in Inflammatory Bowel Disease].
Acta Med Port. 2016
Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab.
J Crohns Colitis. 2016
Anaemia in Patients with Inflammatory Bowel Disease - A Nationwide Cross-Sectional Study.
Digestion. 2016
In vitro evaluation of traditionally used Surinamese medicinal plants for their potential anti-leishmanial efficacy.
J Ethnopharmacol. 2016
Assessing overall patient satisfaction in inflammatory bowel disease using structural equation modeling.
Eur J Gastroenterol Hepatol. 2015
Clinical practice in Crohn's disease in bordering regions of two countries: different medical options, distinct surgical events.
J Crohns Colitis. 2010
Ulcerative colitis in northern Portugal and Galicia in Spain.
Inflamm Bowel Dis. 2010
Ulcerative colitis in a Southern European country: a national perspective.
Inflamm Bowel Dis. 2010
Crohn's disease in a southern European country: Montreal classification and clinical activity.
Inflamm Bowel Dis. 2009
Inflammatory bowel disease: a patient's and caregiver's perspective.
Dig Dis Sci. 2009
Abstracts GEDII
2008
Journal of Crohn and Colitis Suplements - Abstracts of the 3rd ECCO Congress
- A Pharmaco-Epidiemiological approach to estimate IBD prevalence and incidence in Portugal
- Clinical Characteristics of Portuguese Crown´s Disease patients
- Natural history of Portuguese Chrohn´s Disease patients
- Ulcerative Colitis in a South-European Country, a National Perspective
Jornal Português de Gastrenterologia - Vilamoura 4 a 7 de Junho de 2008
- Estudo Genótipo-Fenótipo em doentes com doença de Crohn
- Classificação de Montreal em doentes Portugueses com colite ulcerosa
- Impacto da doença inflamatória intestinal na qualidade de vida – Avaliação Nacional
- Impacto da doença inflamatória intestinal na qualidade de vida dos cuidadores dos doentes
2007
Jornal Português de Gastrenterologia - XXVII Congresso Nacional de Gastrenterologia e Endoscopia Digestiva
- A Pharmacoepidemiological approach to estimate the prevalence and incidence of inflammatory bowel disease (ibd) in Portugal
- Avaliação nacional dos doentes com Doença de Crohn (DC) / Avaliação nacional dos doentes com Colite Ulcerosa (CU)
Agenda
De 04 de abril a 06 de abril de 2024
Reunião Anual 2024
